Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000823306 | SCV000964160 | uncertain significance | Early myoclonic encephalopathy | 2022-09-01 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 665096). This variant has not been reported in the literature in individuals affected with JMJD1C-related conditions. This variant is present in population databases (rs773518308, gnomAD 0.007%). This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 1313 of the JMJD1C protein (p.Thr1313Ala). |
Ambry Genetics | RCV004029140 | SCV004889524 | uncertain significance | not specified | 2023-11-13 | criteria provided, single submitter | clinical testing | The c.3937A>G (p.T1313A) alteration is located in exon 10 (coding exon 10) of the JMJD1C gene. This alteration results from a A to G substitution at nucleotide position 3937, causing the threonine (T) at amino acid position 1313 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |